Disease Modification and Progression in Pre-Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Workshop Report

By afschroeder • February 12, 2026

Putcha N, Bhatt SP, Bon J, Christenson SA, Han MK, Krishnan JA, Martinez FJ, Casaburi R, Crapo JD, Curtis JL, Diette GB, Dransfield MT, Eakin MN, Kalhan R, Mannino DM, Montes de Oca M, Musick H, Rowe SM, Smith BM, Salvi S, Soler X, Wedzicha JA, Wright JA, Woodruff PG, Wise RA, Chang V, Miller BE, Crim C, Drummond MB; American Thoracic Society Clinical Problems Assembly and the American Thoracic Society Drug/Device Discovery and Development Committee. Disease Modification and Progression in Pre-Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2026 Feb 11:aaoag034. doi: 10.1093/annalsats/aaoag034. Epub ahead of print. PMID: 41671101.

Tags: Chronic Obstructive Pulmonary Disease, clinical trials, disease progression, Harbor UCLA, pre-COPD, Publications, Pulmonary, Critical Care & Sleep Medicine, respiratory function test

Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events

Verghese D, Trujillo R, Abraham D, McClelland RL, Kinninger A, Manubolu S, Aldana J, Cubeddu RJ, Drachman D, Inglessis-Azuaje I, Wang DD, Fahed A, Brumback[...]

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

Abuknesha NR, O'Keefe JH, Qian F, Tintle NL, Lin Y, Sun Y, Qian HZ, Aisen PS, Albert CM, Aronson WJ, Asbeutah AAA, Bischoff-Ferrari HA, Budoff[...]

Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes

Hamad CD, Wiener J, Golzar A, Kaur H, Henein C, Kittredge AP, Su G, Kaelber DC, Chan L, Yeaman MR, Adams JS, Bernthal NM, Sheppard[...]